Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Exelixis Inc. Common Stock (EXEL) vs iShares MSCI India ETF (INDA) Price & Performance

Exelixis Inc. Common StockTrade
iShares MSCI India ETFTrade

Price performance (Past 24H)

Key statistics

Exelixis Inc. Common Stock vs iShares MSCI India ETF — how do they compare? Exelixis Inc. Common Stock trades at $58.72 (market cap $14.62B), while iShares MSCI India ETF trades at $45.94 (market cap $5.73B). The key difference: Exelixis Inc. Common Stock is far larger — about 2.6× iShares MSCI India ETF's market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, iShares MSCI India ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and iShares MSCI India ETF for 57 Days on average.

EXELINDA
Market Cap
$14.62B$5.73B
Volume
2,684,9576,797,522
Sector
HealthBroad Market / Factor
52-Week High
$59.13$55.29
52-Week Low
$34.54$45.42
Typical Hold Time
0 Days57 Days
Enterprise Value
$13.95B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Exelixis Inc. Common Stock

No Aura AI signal available yet.

iShares MSCI India ETF

INDA is trading at $46.12, down 1.31% with a bearish technical signal across moving averages and oscillators. The ETF faces headwinds from India's economic challenges including coal power shortages, below-average monsoon rains, and pharmaceutical sector export issues. Technical indicators show oversold conditions with RSI readings below 30, while support and resistance cluster around $46.

The outlook remains cautious given India's infrastructure constraints and global trade tensions. Investment opportunity exists for long-term exposure to India's growth story, but risks include energy security concerns, weather-related agricultural impacts, and IT sector weakness. Current technical oversold conditions may present entry points for patient investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EXEL
100% Buy0% Sell
Avg holding period · 0 Days
INDA
3% Buy97% Sell
Avg holding period · 57 Days

About Exelixis Inc. Common Stock

Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.

Read more on EXEL →

About iShares MSCI India ETF

INDA tracks the MSCI India Index, providing broad exposure to large and mid-cap companies in the Indian stock market. It is structurally dominated by the financials, information technology, and energy sectors, serving as a core instrument for investors seeking a single-country view of India's long-term economic growth.

Read more on INDA →